Skip to the page

Data / Form D filings / BlueWhale Bio, Inc.

BlueWhale Bio, Inc.: Form D filing

BlueWhale Bio, Inc., a biotechnology company in Philadelphia, PA, filed a Form D with the SEC in 2025. The latest, on October 16, 2025, reports $5 million sold of a $15 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
2929 ARCH ST, Philadelphia, PA, 19104
Phone
(617) 595-7783
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2022
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1989669

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 16, 2025New notice$15,000,000$5,000,000$10,000,0001Oct 10, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Elaine HeronDirector
Peter KellerExecutive Officer, Director
Paul MeisterDirector
Paula CannonDirector
Beate Mueller-TiemannDirector

Other biotechnology companies in Pennsylvania that filed recently

Every Form D from the week of Oct 13, 2025 · All recent filings in Pennsylvania · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what BlueWhale Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.